K Oberg1, B Eriksson, E T Janson. Show Affiliations » 1. Department of Internal Medicine, University Hospital, Uppsala, Sweden.
Abstract
Entities: Disease
Mesh: See more » Carcinoid Tumor/therapyHumansInterferon Type I/adverse effectsInterferon Type I/therapeutic useInterferon-alpha/adverse effectsInterferon-alpha/therapeutic useNeuroendocrine Tumors/therapyPancreatic Neoplasms/therapyRecombinant ProteinsStomach Neoplasms/therapy
Substances: See more » Interferon Type IInterferon-alphaRecombinant Proteins
Year: 1994 PMID: 7978897 DOI: 10.1111/j.1749-6632.1994.tb17297.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691